In certain groups of men, glucose-6-phosphate dehydrogenase (G6PD) deficiency was linked with an increased likelihood of severe COVID-19, a Veterans Affairs cohort study found. In Black men under 65, ...

A Chiesi Farmaceutici drug for a rare enzyme deficiency is now approved by the FDA, making it the first U.S. treatment for a disorder that leads to a range of cognitive and muscle problems. The ...

Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...

If you’ve been struggling with bloating, gas, or cramping after meals and have gone down the rabbit hole of low-FODMAP diets and elimination protocols, you might be treating the wrong problem. While ...

Although some small studies suggest that digestive enzymes may help reduce bloating and other gastrointestinal (GI) symptoms, there is not enough clinical evidence to support this. Digestive enzymes ...